Holen Sie sich die Stockscreener-App
9.99
0.30%
0.03
Handel nachbörslich:
10.07
0.08
+0.80%
Certara Inc Aktie (CERT) Neueste Nachrichten
(CERT) Proactive Strategies - Stock Traders Daily
Certara (NASDAQ:CERT) Sets New 52-Week LowShould You Sell? - MarketBeat
Certara stock hits 52-week low at $9.98 amid market challenges - Investing.com
WASATCH ADVISORS LP Expands Stake in Certara Inc - GuruFocus.com
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 - Insider Monkey
Certara's SWOT analysis: biosimulation firm navigates market shifts - Investing.com India
Certara's SWOT analysis: biosimulation firm navigates market shifts By Investing.com - Investing.com Australia
Certara, Inc. (NASDAQ:CERT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Certara (NASDAQ:CERT) Announces Earnings Results - MarketBeat
Certara, Inc. (NASDAQ:CERT) Q3 2024 Earnings Call Transcript - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Certara - Benzinga
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Barclays - MarketBeat
Certara price target lowered to $12 from $14 at Barclays - TipRanks
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Certara reports Q3 adjusted EPS 13c, consensus 11c - TipRanks
Certara, Inc. Reports Q3 2024 Financial Growth - TipRanks
Certara Inc Reports Q3 2024 Revenue of $94.8M, GAAP EPS Loss of $0.01, Aligns with Estimates - GuruFocus.com
Certara Reports Third Quarter 2024 Financial Results - The Manila Times
Certara Q3 Revenue Surges 11% to $94.8M, Software Growth Leads with 15% Jump | CERT Stock News - StockTitan
Objective long/short (CERT) Report - Stock Traders Daily
Certara narrows FY24 adjusted EPS view to 41c-44c from 41c-46c - TipRanks
Robert W. Baird Lowers Certara (NASDAQ:CERT) Price Target to $13.00 - MarketBeat
Certara stock target cut, maintains neutral rating amid spending concerns - Investing.com India
Certara stock target cut, maintains neutral rating amid spending concerns By Investing.com - Investing.com South Africa
Certara price target lowered to $13 from $18 at Baird - TipRanks
Drug Discovery Informatics Market Size Set to Surpass USD - GlobeNewswire
Biosimulation Market Segments, Drivers, Restraints, And Trends For 2024-2033 - EIN News
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Certara (CERT) to Release Quarterly Earnings on Wednesday - MarketBeat
Certara to Participate in the Stephens Annual Investment Conference - The Manila Times
Certara To Participate In The Stephens Annual Investment Conference - Barchart
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate - Yahoo Finance
How To Trade (CERT) - Stock Traders Daily
Certara (NASDAQ:CERT) Hits New 12-Month LowHere's Why - MarketBeat
Certara stock hits 52-week low at $10.35 amid market challenges - Investing.com
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued? - Simply Wall St
Certara (NASDAQ:CERT) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Analysts Set Certara, Inc. (NASDAQ:CERT) Target Price at $17.08 - MarketBeat
Globe Life Inc. (NYSE:GL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Certara appoints new director to its board By Investing.com - Investing.com Australia
Certara Appoints John Reynders as Board Member - citybiz
Certara appoints new director to its board - Investing.com India
Certara Appoints John Reynders as New Independent Board Member - The Manila Times
Certara adds pharmaceutical veteran to board By Investing.com - Investing.com UK
380,638 Shares in Certara, Inc. (NASDAQ:CERT) Bought by Kopion Asset Management LLC - MarketBeat
Barclays Lowers Certara (NASDAQ:CERT) Price Target to $14.00 - MarketBeat
Beyond The Numbers: 4 Analysts Discuss Certara Stock - Benzinga
Trading Day Review: Certara Inc (CERT) Loses Momentum, Closing at 11.24 - The Dwinnex
Certara price target lowered to $14 from $16 at Barclays - TipRanks
Certara Inc (CERT) is looking forward to a strong quarter - SETE News
In Silico Clinical Trials Market 2024-2031- Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes - IndiaPolitics.com
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 - The Manila Times
Taking a Closer Look At Certara Inc (CERT) Following Its Recent Trade - Knox Daily
A stock that deserves closer examination: Certara Inc (CERT) - US Post News
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):